Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
McCarthy Sean A.
CEO at CytomX Therapeutics. Filing since 3 Mar 2017.
CIK 0001654058
Company
Date
Role
Action
Shares
Amount
Of holding
CTMX
CytomX Therapeutics, Inc.
17 Mar 2026
CEO
Sold on a plan
118,969
$764.14K
9.9%
CTMX
CytomX Therapeutics, Inc.
6 Nov 2025
CEO
Sold on a plan
101,793
$461.91K
9.3%
CTMX
CytomX Therapeutics, Inc.
16 Jun 2025
CEO
Sold at will
55,511
$149.26K
4.8%
CTMX
CytomX Therapeutics, Inc.
18 Mar 2025
CEO
Sold at will
37,656
$22.56K
3.6%
CTMX
CytomX Therapeutics, Inc.
20 Aug 2024
CEO
Sold at will
13,898
$17.08K
2.1%
CTMX
CytomX Therapeutics, Inc.
19 Mar 2024
CEO
Sold at will
20,223
$42.18K
3.7%
CTMX
CytomX Therapeutics, Inc.
20 Dec 2023
CEO
Sold at will
13,551
$18.71K
2.9%
CTMX
CytomX Therapeutics, Inc.
22 Sep 2023
CEO
Sold at will
14,601
$18.99K
3.3%
CTMX
CytomX Therapeutics, Inc.
16 Mar 2023
CEO
Sold at will
7,121
$13.39K
1.8%
CTMX
CytomX Therapeutics, Inc.
20 Jul 2022
President and CEO
Sold, plan not stated
14,911
$21.21K
4.9%
CTMX
CytomX Therapeutics, Inc.
16 Jun 2021
President and CEO
Sold, plan not stated
100,000
$704.47K
51.8%
CTMX
CytomX Therapeutics, Inc.
31 Mar 2021
President and CEO
Sold, plan not stated
100,000
$749.47K
32.6%
CTMX
CytomX Therapeutics, Inc.
12 May 2020
President and CEO
Sold, plan not stated
36,000
$540.00K
29.9%
CTMX
CytomX Therapeutics, Inc.
2 Nov 2018
President and CEO
Sold, plan not stated
1,156
$17.35K
1.4%
CTMX
CytomX Therapeutics, Inc.
1 Nov 2018
President and CEO
Sold, plan not stated
5,370
$80.55K
6.1%
CTMX
CytomX Therapeutics, Inc.
4 Sep 2018
President and CEO
Sold, plan not stated
13,052
$285.34K
13.7%
CTMX
CytomX Therapeutics, Inc.
5 Jul 2018
President and CEO
Sold, plan not stated
4,497
$112.69K
5.2%
CTMX
CytomX Therapeutics, Inc.
3 Jul 2018
President and CEO
Sold, plan not stated
2,028
$50.88K
2.4%
CTMX
CytomX Therapeutics, Inc.
2 Jul 2018
President and CEO
Sold, plan not stated
13,052
$305.71K
13.7%
CTMX
CytomX Therapeutics, Inc.
1 May 2018
President and CEO
Sold, plan not stated
19,578
$519.74K
80.8%
CTMX
CytomX Therapeutics, Inc.
1 Mar 2018
President and CEO
Sold, plan not stated
19,578
$576.14K
80.8%
CTMX
CytomX Therapeutics, Inc.
5 Jan 2018
President and CEO
Sold, plan not stated
6,526
$163.22K
58.4%
CTMX
CytomX Therapeutics, Inc.
2 Jan 2018
President and CEO
Sold, plan not stated
13,052
$274.61K
73.8%
CTMX
CytomX Therapeutics, Inc.
1 Dec 2017
President and CEO
Sold, plan not stated
14,340
$295.40K
75.5%
CTMX
CytomX Therapeutics, Inc.
1 Nov 2017
President and CEO
Sold, plan not stated
14,342
$284.83K
77.2%
CTMX
CytomX Therapeutics, Inc.
4 Oct 2017
President and CEO
Sold, plan not stated
19,120
$461.37K
81.8%
CTMX
CytomX Therapeutics, Inc.
2 Oct 2017
President and CEO
Sold, plan not stated
9,562
$177.57K
69.3%
CTMX
CytomX Therapeutics, Inc.
1 Sep 2017
President and CEO
Sold, plan not stated
9,930
$171.99K
70.1%
CTMX
CytomX Therapeutics, Inc.
31 Aug 2017
President and CEO
Sold, plan not stated
18,756
$328.26K
81.5%
CTMX
CytomX Therapeutics, Inc.
9 Aug 2017
President and CEO
Sold, plan not stated
4,781
$71.72K
53.0%
CTMX
CytomX Therapeutics, Inc.
3 Jul 2017
President and CEO
Sold, plan not stated
4,781
$74.20K
53.0%
CTMX
CytomX Therapeutics, Inc.
26 Jun 2017
President and CEO
Bought
4,481
$67.22K
opened
CTMX
CytomX Therapeutics, Inc.
5 Jun 2017
President and CEO
Sold, plan not stated
300
$4.50K
6.6%
CTMX
CytomX Therapeutics, Inc.
1 May 2017
President and CEO
Sold, plan not stated
4,781
$75.06K
70.7%
CTMX
CytomX Therapeutics, Inc.
4 Apr 2017
President and CEO
Sold, plan not stated
4,781
$83.67K
70.7%
CTMX
CytomX Therapeutics, Inc.
3 Apr 2017
President and CEO
Sold, plan not stated
4,781
$80.99K
70.7%
CTMX
CytomX Therapeutics, Inc.
20 Mar 2017
President and CEO
Sold, plan not stated
14,343
$281.12K
87.9%
CTMX
CytomX Therapeutics, Inc.
3 Mar 2017
President and CEO
Sold, plan not stated
14,343
$215.15K
87.9%
38 decisions on file.
